News about L'OREAL

  • Local
  • International
  • Company messages
07 Sep
 
24 Aug
 
01 Aug
 
01 Aug
 
26 Jul
 
05 Jul
 
20 Jun
 
08 Jun
 
31 May
 
29 May
 
28 May
 
25 May
 
21 May
 
15 May
 
15 May
 
07 May
 
03 May
 
02 May
 
17 Apr
 
17 Apr
 

Popular news

1
Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services
2
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers – OPK
3
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
4
InsurTech transactions reach new peak in Q2; 5-year Life & Health InsurTech investment exceeds $5 billion
5
Plexus Celebrates the Opening of the Enhanced Penang Design Center
6
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
7
Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients
8
CADWorx® & Analysis Solutions releases new CADWorx Design Review Professional for model visualization and publishing
9
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
10
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rockwell, GDS Holdings, and Zion and Encourages Investors to Contact the Firm

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 September 2018 09:00:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB3 - 2018-09-24 10:00:37 - 2018-09-24 09:00:37 - 1000 - Website: OKAY